knowledge
Previous article:
Moonlake's readout produced a cash windfall. Risks remain
Next article: As JPM 2024 winds down, some health tech firms project optimism
Next article: As JPM 2024 winds down, some health tech firms project optimism
leisure time
focus
-
Caregivers of transplant patients call for more support, training
2025-09-30 00:59 -
Fauci’s Covid grilling leads GOP to weigh foreign research rules
2025-09-30 00:43 -
Antibiotic resistance and the global rise in human conflict
2025-09-30 00:02 -
As JPM 2024 winds down, some health tech firms project optimism
2025-09-29 23:46 -
At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves
2025-09-29 23:39 -
J&J to buy cancer drug developer Ambrx Biopharma
2025-09-29 23:31